Skip to main content
Polaris AI Pharma Corp. logo

Polaris AI Pharma Corp. — Investor Relations & Filings

Ticker · 041910 ISIN · KR7041910001 KO Manufacturing
Open in API
Filings indexed 164 across all filing types
Latest filing 2024-03-08 Proxy Solicitation & In…
Country KR South Korea
Listing KO 041910

About Polaris AI Pharma Corp.

https://polarisaipharma.com/

Polaris AI Pharma Corp., formerly known as ESTECHPHARMA CO., LTD, is a company engaged in the development, manufacture, and supply of active pharmaceutical ingredients (APIs) and fine chemicals. The company specializes in producing raw materials for generic drugs across various therapeutic categories. Its product portfolio includes APIs for treatments such as anti-thrombosis, anti-ulcer, asthma, and alcohol dependence.

Recent filings

Filing Released Lang Actions
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea (often associated with the Financial Supervisory Service/KRX) used to solicit shareholder votes for an upcoming Annual General Meeting (AGM). It contains details about the meeting date, agenda items (such as approval of financial statements, election of directors, etc.), and proxy voting procedures. While it contains financial statements, these are provided as part of the proxy solicitation materials for the AGM, not as a standalone annual report or audit report. Therefore, it is classified as Proxy Solicitation & Information Statement.
2024-03-08 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act (Article 147). It details changes in share ownership, specifically regarding a change in management control and major shareholding status. This type of filing is classified as a Major Shareholding Notification (MRQ) in the provided schema.
2024-03-05 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from a Korean company (Estechpharma) detailing a decision for a third-party capital increase (유상증자결정). It includes specific details on share issuance, pricing, and the entities involved in the capital raise. This falls under the category of share issuance and capital changes.
2024-02-29 Korean
최대주주변경을수반하는주식양수도계약체결
Major Shareholding Notification Classification · 100% confidence The document is a formal regulatory announcement regarding a change in the company's largest shareholder (maximum shareholder) due to a stock purchase agreement. It details the parties involved, the transaction amount, the payment schedule, and the impact on management control. This type of disclosure is a standard regulatory filing in the Korean market (DART system) concerning corporate control and ownership structure changes, which falls under the 'Regulatory Filings' category as it does not fit into specific categories like M&A (which usually implies a merger of entities) or Director's Dealing (which is for individual insider trades).
2024-02-29 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Services Commission and the Korea Exchange. It details the acquisition of shares and management rights of 'S-Tech Pharma' by 'Polaris Office' and its special related parties. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) as it reports changes in significant share ownership levels crossing regulatory thresholds.
2024-02-29 Korean
[기재정정]최대주주변경을수반하는주식양수도계약체결
Major Shareholding Notification Classification · 100% confidence The document is a regulatory filing from a Korean company (에스텍파마) regarding a 'Change in Largest Shareholder' due to a stock purchase agreement. This type of disclosure, which details changes in ownership, control, and management, is classified as a regulatory filing (RNS) in the absence of a more specific category like 'Major Shareholding Notification' (which usually refers to institutional investors crossing thresholds) or 'Director's Dealing' (which refers to individual insider trades). It is a formal corporate announcement of a material event.
2024-02-29 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.